Nasdaq · ADR
Lakefront Biotherapeutics (LKFT)
$31.69 +$0.04 (+0.11%)
- Day’s range
- $31.62–$32.00
- Volume
- 191,348
LKFT price history
LKFT closed at $31.69 on Oct. 26, 2026. Over the past year, its daily close ranged from $26.08 on Aug. 5, 2026 to $31.69 on Oct. 26, 2026.
Data table: LKFT daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $31.69 |
| Oct. 23, 2026 | $31.65 |
| Oct. 22, 2026 | $31.40 |
| Oct. 21, 2026 | $30.58 |
| Oct. 20, 2026 | $30.75 |
| Oct. 19, 2026 | $29.79 |
| Oct. 16, 2026 | $29.90 |
| Oct. 15, 2026 | $29.93 |
| Oct. 14, 2026 | $29.40 |
| Oct. 13, 2026 | $29.05 |
| Oct. 12, 2026 | $29.57 |
| Oct. 9, 2026 | $29.73 |
| Oct. 8, 2026 | $29.51 |
| Oct. 7, 2026 | $30.00 |
| Oct. 6, 2026 | $29.32 |
| Oct. 5, 2026 | $29.51 |
| Oct. 2, 2026 | $29.37 |
| Oct. 1, 2026 | $28.86 |
| Sept. 30, 2026 | $29.65 |
| Sept. 29, 2026 | $29.52 |
| Sept. 28, 2026 | $29.84 |
| Sept. 25, 2026 | $29.38 |
| Sept. 24, 2026 | $30.36 |
| Sept. 23, 2026 | $30.72 |
| Sept. 22, 2026 | $30.19 |
| Sept. 21, 2026 | $29.59 |
| Sept. 18, 2026 | $28.55 |
| Sept. 17, 2026 | $28.91 |
| Sept. 16, 2026 | $27.53 |
| Sept. 15, 2026 | $27.92 |
| Sept. 14, 2026 | $26.71 |
| Sept. 11, 2026 | $26.81 |
| Sept. 10, 2026 | $26.81 |
| Sept. 9, 2026 | $27.43 |
| Sept. 8, 2026 | $27.63 |
| Sept. 4, 2026 | $28.49 |
| Sept. 3, 2026 | $29.02 |
| Sept. 2, 2026 | $28.81 |
| Sept. 1, 2026 | $28.55 |
| Aug. 31, 2026 | $28.50 |
| Aug. 28, 2026 | $28.88 |
| Aug. 27, 2026 | $29.44 |
| Aug. 26, 2026 | $29.16 |
| Aug. 25, 2026 | $29.70 |
| Aug. 24, 2026 | $29.04 |
| Aug. 21, 2026 | $28.80 |
| Aug. 20, 2026 | $28.27 |
| Aug. 19, 2026 | $29.36 |
| Aug. 18, 2026 | $27.99 |
| Aug. 17, 2026 | $27.52 |
| Aug. 14, 2026 | $27.53 |
| Aug. 13, 2026 | $28.04 |
| Aug. 12, 2026 | $27.93 |
| Aug. 11, 2026 | $28.73 |
| Aug. 10, 2026 | $26.91 |
| Aug. 7, 2026 | $27.00 |
| Aug. 6, 2026 | $26.13 |
| Aug. 5, 2026 | $26.08 |
| Aug. 4, 2026 | $26.45 |
| Aug. 3, 2026 | $26.74 |
| July 31, 2026 | $27.21 |
| July 30, 2026 | $27.64 |
| July 29, 2026 | $27.72 |
| July 28, 2026 | $28.15 |
| July 27, 2026 | $28.13 |
| July 24, 2026 | $27.84 |
| July 23, 2026 | $28.12 |
| July 22, 2026 | $28.78 |
| July 21, 2026 | $29.23 |
| July 20, 2026 | $29.02 |
| July 17, 2026 | $30.01 |
| July 16, 2026 | $29.60 |
| July 15, 2026 | $29.48 |
| July 14, 2026 | $29.47 |
| July 13, 2026 | $29.80 |
| July 10, 2026 | $30.27 |
| July 9, 2026 | $30.59 |
| July 8, 2026 | $30.81 |
| July 7, 2026 | $30.58 |
| July 6, 2026 | $30.35 |
| July 2, 2026 | $30.39 |
| July 1, 2026 | $29.60 |
| June 30, 2026 | $29.98 |
| June 29, 2026 | $29.67 |
| June 26, 2026 | $29.48 |
| June 25, 2026 | $28.84 |
| June 24, 2026 | $29.01 |
| June 23, 2026 | $29.05 |
| June 22, 2026 | $28.94 |
| June 18, 2026 | $28.30 |
| June 17, 2026 | $28.37 |
| June 16, 2026 | $28.18 |
| June 15, 2026 | $28.66 |
| June 12, 2026 | $28.90 |
| June 11, 2026 | $28.94 |
| June 10, 2026 | $28.61 |
| June 9, 2026 | $28.27 |
| June 8, 2026 | $27.83 |
| June 5, 2026 | $28.02 |
| June 4, 2026 | $28.11 |
| June 3, 2026 | $27.51 |
| June 2, 2026 | $27.27 |
| June 1, 2026 | $27.54 |
| May 29, 2026 | $28.35 |
| May 28, 2026 | $28.32 |
| May 27, 2026 | $27.73 |
| May 26, 2026 | $27.67 |
| May 22, 2026 | $27.49 |
| May 21, 2026 | $27.77 |
| May 20, 2026 | $27.40 |
| May 19, 2026 | $26.61 |
| May 18, 2026 | $26.69 |
| May 15, 2026 | $27.05 |
| May 14, 2026 | $27.49 |
| May 13, 2026 | $28.14 |
| May 12, 2026 | $27.33 |
| May 11, 2026 | $27.45 |
| May 8, 2026 | $28.59 |
Key figures
- 52-week range
- —
- Average daily volume
- 286,322Past 3 months
- Market value
- $2.09B
- Dividend yield
- —
- From 52-week high
- —
Price change
- 1 month
- +7.85%
- 3 months
- +13.81%
- Year to date
- —
- 1 year
- —
What Wall Street says about LKFT
In the past 90 days, Wall Street firms published 3 rating or price-target actions on LKFT: 1 upgrade and 2 lowered price targets.
| Action | Rating | |||
|---|---|---|---|---|
| RBC Capital | Upgrade | Sector perform to Outperform | $26 to $45 | |
| Morgan Stanley | Cuts target | Equal-weight | $30 to $26 | |
| RBC Capital | Cuts target | Sector perform | $28 to $26 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
- Employees
- 452
- Listed
- Dec. 18, 2008
In WallStreetDigest editions
No WallStreetDigest article about LKFT is on the site yet.